## **Core Concept**
The pneumococcal vaccine is administered to protect against infections caused by *Streptococcus pneumoniae*, a common cause of bacterial pneumonia, meningitis, and otitis media. The vaccine is particularly important for certain high-risk groups. The primary aim is to induce immunity against the capsular polysaccharides of pneumococcus.

## **Why the Correct Answer is Right**
The pneumococcal vaccine, especially the pneumococcal conjugate vaccine (PCV), is recommended for children under the age of 2 years, as well as for adults aged 65 years and older, and certain younger adults with specific chronic medical conditions. This vaccine helps prevent pneumococcal disease, which can manifest as pneumonia, bacteremia, or meningitis. The conjugate vaccine is crucial for young children because it induces an immune response against multiple serotypes of pneumococcus, providing broad protection.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Incorrect because while pneumococcal vaccine might be considered for certain individuals with specific medical conditions or those who are immunocompromised, option A does not accurately represent a universally recommended group for pneumococcal vaccination.
- **Option B:** Incorrect because this option does not specifically align with standard recommendations for pneumococcal vaccination, which typically emphasize children under 2, adults over 65, and certain at-risk younger adults.
- **Option D:** Incorrect because, similar to option A, it does not accurately capture the primary groups targeted for pneumococcal vaccination.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the pneumococcal conjugate vaccine (PCV) is specifically designed to protect against multiple serotypes of *Streptococcus pneumoniae* and is recommended for children at a young age (typically a series starting at 2 months of age), as well as for older adults. This vaccine is critical for preventing severe pneumococcal disease.

## **Correct Answer:** .